메뉴 건너뛰기




Volumn 40, Issue 5, 2013, Pages 728-736

18F-FDG PET SUVmax as an indicator of histopathologic response after neoadjuvant chemotherapy in extremity osteosarcoma

Author keywords

FDGPET; Histologic response; Osteosarcoma; SUVmax

Indexed keywords

CISPLATIN; DOXORUBICIN; FLUORODEOXYGLUCOSE F 18; GADODIAMIDE; GADOLINIUM; MEDRONATE TECHNETIUM TC 99M; METHOTREXATE; DIAGNOSTIC AGENT;

EID: 84891695934     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-013-2344-8     Document Type: Article
Times cited : (55)

References (32)
  • 1
    • 0036467661 scopus 로고    scopus 로고
    • Prognostic factors in high-grade osteosarcoma of the extremities or trunk: An analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols
    • Bielack SS, Kempf-Bielack B, Delling G, Exner GU, Flege S, Helmke K, et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol. 2002;20:776-90.
    • (2002) J Clin Oncol , vol.20 , pp. 776-790
    • Bielack, S.S.1    Kempf-Bielack, B.2    Delling, G.3    Exner, G.U.4    Flege, S.5    Helmke, K.6
  • 2
    • 65549092332 scopus 로고    scopus 로고
    • Prognostic nomogram for predicting the 5-year probability of developing metastasis after neo-adjuvant chemotherapy and definitive surgery for AJCC stage II extremity osteosarcoma
    • Kim MS, Lee SY, Lee TR, Cho WH, Song WS, Koh JS, et al. Prognostic nomogram for predicting the 5-year probability of developing metastasis after neo-adjuvant chemotherapy and definitive surgery for AJCC stage II extremity osteosarcoma. Ann Oncol. 2009;20:955-60.
    • (2009) Ann Oncol , vol.20 , pp. 955-960
    • Kim, M.S.1    Lee, S.Y.2    Lee, T.R.3    Cho, W.H.4    Song, W.S.5    Koh, J.S.6
  • 3
    • 0018650014 scopus 로고
    • Primary osteogenic sarcoma: The rationale for preoperative chemotherapy and delayed surgery
    • Rosen G, Marcove RC, Caparros B, Nirenberg A, Kosloff C, Huvos AG. Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery. Cancer. 1979;43:2163-77.
    • (1979) Cancer , vol.43 , pp. 2163-2177
    • Rosen, G.1    Marcove, R.C.2    Caparros, B.3    Nirenberg, A.4    Kosloff, C.5    Huvos, A.G.6
  • 4
    • 0020059356 scopus 로고
    • Preoperative chemotherapy for osteogenic sarcoma: Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy
    • Rosen G, Caparros B, Huvos AG, Kosloff C, Nirenberg A, Cacavio A, et al. Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer. 1982;49:1221-30.
    • (1982) Cancer , vol.49 , pp. 1221-1230
    • Rosen, G.1    Caparros, B.2    Huvos, A.G.3    Kosloff, C.4    Nirenberg, A.5    Cacavio, A.6
  • 7
    • 48749118413 scopus 로고    scopus 로고
    • Response of osteogenic sarcoma to neoadjuvant therapy: Evaluated by 18FFDG- PET
    • Ye Z, Zhu J, Tian M, Zhang H, Zhan H, Zhao C, et al. Response of osteogenic sarcoma to neoadjuvant therapy: evaluated by 18FFDG- PET. Ann Nucl Med. 2008;22:475-80.
    • (2008) Ann Nucl Med , vol.22 , pp. 475-480
    • Ye, Z.1    Zhu, J.2    Tian, M.3    Zhang, H.4    Zhan, H.5    Zhao, C.6
  • 8
    • 0037096805 scopus 로고    scopus 로고
    • Evaluation of chemotherapy response in pediatric bone sarcomas by [F-18]-fluorodeoxy-D-glucose positron emission tomography
    • Hawkins DS, Rajendran JG, Conrad 3rd EU, Bruckner JD, Eary JF. Evaluation of chemotherapy response in pediatric bone sarcomas by [F-18]-fluorodeoxy-D- glucose positron emission tomography. Cancer. 2002;94:3277-84.
    • (2002) Cancer , vol.94 , pp. 3277-3284
    • Hawkins, D.S.1    Rajendran, J.G.2    Conrad III, E.U.3    Bruckner, J.D.4    Eary, J.F.5
  • 9
    • 0036326395 scopus 로고    scopus 로고
    • Prognostic significance of (18)F-FDG and (99m)Tc-methylene diphosphonate uptake in primary osteosarcoma
    • Franzius C, Bielack S, Flege S, Sciuk J, Jurgens H, Schober O. Prognostic significance of (18)F-FDG and (99m)Tc-methylene diphosphonate uptake in primary osteosarcoma. J Nucl Med. 2002;43:1012-7.
    • (2002) J Nucl Med , vol.43 , pp. 1012-1017
    • Franzius, C.1    Bielack, S.2    Flege, S.3    Sciuk, J.4    Jurgens, H.5    Schober, O.6
  • 12
    • 46749118451 scopus 로고    scopus 로고
    • Treatment monitoring by 18FFDG PET/CT in patients with sarcomas: Interobserver variability of quantitative parameters in treatment-induced changes in histopathologically responding and nonresponding tumors
    • Benz MR, Evilevitch V, Allen-Auerbach MS, Eilber FC, Phelps ME, Czernin J, et al. Treatment monitoring by 18FFDG PET/CT in patients with sarcomas: interobserver variability of quantitative parameters in treatment-induced changes in histopathologically responding and nonresponding tumors. J Nucl Med. 2008;49:1038-46.
    • (2008) J Nucl Med , vol.49 , pp. 1038-1046
    • Benz, M.R.1    Evilevitch, V.2    Allen-Auerbach, M.S.3    Eilber, F.C.4    Phelps, M.E.5    Czernin, J.6
  • 13
    • 77949424147 scopus 로고    scopus 로고
    • Tumor necrosis in osteosarcoma: Inclusion of the point of greatest metabolic activity from F-18 FDG PET/CT in the histopathologic analysis
    • Costelloe CM, Raymond AK, Fitzgerald NE, Mawlawi OR, Nunez RF, Madewell JE, et al. Tumor necrosis in osteosarcoma: inclusion of the point of greatest metabolic activity from F-18 FDG PET/CT in the histopathologic analysis. Skeletal Radiol. 2010;39:131-40.
    • (2010) Skeletal Radiol , vol.39 , pp. 131-140
    • Costelloe, C.M.1    Raymond, A.K.2    Fitzgerald, N.E.3    Mawlawi, O.R.4    Nunez, R.F.5    Madewell, J.E.6
  • 14
    • 39149096261 scopus 로고    scopus 로고
    • Tumor necrosis rate adjusted by tumor volume change is a better predictor of survival of localized osteosarcoma patients
    • Kim MS, Lee SY, Cho WH, Song WS, Koh JS, Lee JA, et al. Tumor necrosis rate adjusted by tumor volume change is a better predictor of survival of localized osteosarcoma patients. Ann Surg Oncol. 2008;15:906-14.
    • (2008) Ann Surg Oncol , vol.15 , pp. 906-914
    • Kim, M.S.1    Lee, S.Y.2    Cho, W.H.3    Song, W.S.4    Koh, J.S.5    Lee, J.A.6
  • 16
    • 11244336678 scopus 로고    scopus 로고
    • Treatment effects in pediatric soft tissue and bone tumors: Practical considerations for the pathologist
    • Coffin CM, Lowichik A, Zhou H. Treatment effects in pediatric soft tissue and bone tumors: practical considerations for the pathologist. Am J Clin Pathol. 2005;123:75-90.
    • (2005) Am J Clin Pathol , vol.123 , pp. 75-90
    • Coffin, C.M.1    Lowichik, A.2    Zhou, H.3
  • 19
    • 55749105515 scopus 로고    scopus 로고
    • An examination of the efficacy of the 8 cm maximal tumor diameter cutoff for the subdivision of AJCC stage II osteosarcoma patients
    • Kim MS, Lee SY, Cho WH, Song WS, Koh JS, Lee JA, et al. An examination of the efficacy of the 8 cm maximal tumor diameter cutoff for the subdivision of AJCC stage II osteosarcoma patients. J Surg Oncol. 2008;98:427-31.
    • (2008) J Surg Oncol , vol.98 , pp. 427-431
    • Kim, M.S.1    Lee, S.Y.2    Cho, W.H.3    Song, W.S.4    Koh, J.S.5    Lee, J.A.6
  • 20
    • 0033787602 scopus 로고    scopus 로고
    • Evaluation of chemotherapy response in primary bone tumors with F-18 FDG positron emission tomography compared with histologically assessed tumor necrosis
    • Franzius C, Sciuk J, Brinkschmidt C, Jurgens H, Schober O. Evaluation of chemotherapy response in primary bone tumors with F-18 FDG positron emission tomography compared with histologically assessed tumor necrosis. Clin Nucl Med. 2000;25:874-81.
    • (2000) Clin Nucl Med , vol.25 , pp. 874-881
    • Franzius, C.1    Sciuk, J.2    Brinkschmidt, C.3    Jurgens, H.4    Schober, O.5
  • 21
    • 33748507112 scopus 로고    scopus 로고
    • Comparison between F-18-FDG positron emission tomography and histology for the assessment of tumor necrosis rates in primary osteosarcoma
    • Huang TL, Liu RS, Chen TH, Chen WY, Hsu HC, Hsu YC. Comparison between F-18-FDG positron emission tomography and histology for the assessment of tumor necrosis rates in primary osteosarcoma. J Chin Med Assoc. 2006;69:372-6.
    • (2006) J Chin Med Assoc , vol.69 , pp. 372-376
    • Huang, T.L.1    Liu, R.S.2    Chen, T.H.3    Chen, W.Y.4    Hsu, H.C.5    Hsu, Y.C.6
  • 22
    • 66149139452 scopus 로고    scopus 로고
    • From RECIST to PERCIST: Evolving considerations for PET response criteria in solid tumors
    • Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med. 2009;50 Suppl 1:122S-50.
    • (2009) J Nucl Med , vol.50 , Issue.SUPPL. 1
    • Wahl, R.L.1    Jacene, H.2    Kasamon, Y.3    Lodge, M.A.4
  • 24
    • 84855409217 scopus 로고    scopus 로고
    • Impact of the definition of peak standardized uptake value on quantification of treatment response
    • Vanderhoek M, Perlman SB, Jeraj R. Impact of the definition of peak standardized uptake value on quantification of treatment response. J Nucl Med. 2012;53:4-11.
    • (2012) J Nucl Med , vol.53 , pp. 4-11
    • Vanderhoek, M.1    Perlman, S.B.2    Jeraj, R.3
  • 26
    • 76249120902 scopus 로고    scopus 로고
    • Early (18)F-2-fluoro-2-deoxy-d-glucose positron emission tomography may identify a subset of patients with estrogen receptor-positive breast cancer who will not respond optimally to preoperative chemotherapy
    • Martoni AA, Zamagni C, Quercia S, Rosati M, Cacciari N, Bernardi A, et al. Early (18)F-2-fluoro-2-deoxy-d-glucose positron emission tomography may identify a subset of patients with estrogen receptor-positive breast cancer who will not respond optimally to preoperative chemotherapy. Cancer. 2010;116:805-13.
    • (2010) Cancer , vol.116 , pp. 805-813
    • Martoni, A.A.1    Zamagni, C.2    Quercia, S.3    Rosati, M.4    Cacciari, N.5    Bernardi, A.6
  • 27
    • 67349209897 scopus 로고    scopus 로고
    • 18F-FDG PET/CT in evaluation of early response to neoadjuvant chemotherapy in patients with locally advanced breast cancer
    • 18F-FDG PET/CT in evaluation of early response to neoadjuvant chemotherapy in patients with locally advanced breast cancer. Eur Radiol. 2009;19:1347-57.
    • (2009) Eur Radiol , vol.19 , pp. 1347-1357
    • Kumar, A.1    Kumar, R.2    Seenu, V.3    Gupta, S.D.4    Chawla, M.5    Malhotra, A.6
  • 28
    • 77950985227 scopus 로고    scopus 로고
    • Value of combined interpretation of computed tomography response and positron emission tomography response for prediction of prognosis after neoadjuvant chemotherapy in non-small cell lung cancer
    • Lee HY, Lee HJ, Kim YT, Kang CH, Jang BG, Chung DH, et al. Value of combined interpretation of computed tomography response and positron emission tomography response for prediction of prognosis after neoadjuvant chemotherapy in non-small cell lung cancer. J Thorac Oncol. 2010;5:497-503.
    • (2010) J Thorac Oncol , vol.5 , pp. 497-503
    • Lee, H.Y.1    Lee, H.J.2    Kim, Y.T.3    Kang, C.H.4    Jang, B.G.5    Chung, D.H.6
  • 30
    • 78649318716 scopus 로고    scopus 로고
    • High FDG uptake in PET/CT predicts worse prognosis in patients with metastatic gastric adenocarcinoma
    • Chung HW, Lee EJ, Cho YH, Yoon SY, So Y, Kim SY, et al. High FDG uptake in PET/CT predicts worse prognosis in patients with metastatic gastric adenocarcinoma. J Cancer Res Clin Oncol. 2010;136:1929-35.
    • (2010) J Cancer Res Clin Oncol , vol.136 , pp. 1929-1935
    • Chung, H.W.1    Lee, E.J.2    Cho, Y.H.3    Yoon, S.Y.4    So, Y.5    Kim, S.Y.6
  • 31
    • 68149150875 scopus 로고    scopus 로고
    • [F-18]-fluorodeoxy-D-glucose-positron emission tomography response is associated with outcome for extremity osteosarcoma in children and young adults
    • Hawkins DS, Conrad 3rd EU, Butrynski JE, Schuetze SM, Eary JF. [F-18]-fluorodeoxy-D-glucose-positron emission tomography response is associated with outcome for extremity osteosarcoma in children and young adults. Cancer. 2009;115:3519-25.
    • (2009) Cancer , vol.115 , pp. 3519-3525
    • Hawkins, D.S.1    Conrad III, E.U.2    Butrynski, J.E.3    Schuetze, S.M.4    Eary, J.F.5
  • 32
    • 84858781687 scopus 로고    scopus 로고
    • 18F-FDG PET/CT indices, after one course and at the completion of neoadjuvant chemotherapy, in children and young adults with osteosarcoma
    • 18F-FDG PET/CT indices, after one course and at the completion of neoadjuvant chemotherapy, in children and young adults with osteosarcoma. Eur J Nucl Med Mol Imaging. 2012;39:39-49.
    • (2012) Eur J Nucl Med Mol Imaging , vol.39 , pp. 39-49
    • Im, H.J.1    Kim, T.S.2    Park, S.Y.3    Min, H.S.4    Kim, J.H.5    Kang, H.G.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.